• Roche (RHHBY) CEO Rules Out Additional Big Job Cuts, Eyes Smaller Deals More...

• Cannabis Science Inc. Acquires "Trimcare Brand" and its Full Medical Clinic Operations in Las Vegas Nevada Specializing in Supplements, Skin Care Products, Food, Weight Loss Programs, and Hormone Products More...

• Protalix Biotherapeutics, Inc. (PLX) Gets $25 Million Payment From Pfizer Inc. (PFE) More...

• Zhifei Biological Products Expands Vaccine Partnership With Merck & Co., Inc. (MRK) More...

• Fundacion MEDINA Announces Drug Discovery Collaboration With Cubist Pharmaceuticals, Inc. (CBST) More...

• HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park More...

• Biodel Inc. (BIOD) Obtains Exclusive License to Aegis Therapeutics, LLC' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations More...

• Knome Appoints Gary A. Cohen as Senior Vice President and General Counsel More...

• Forest Laboratories, Inc. (FRX) Revises Fiscal Year 2013 Earnings Guidance Primarily Due to Evolving Conditions in the Lexapro / escitalopram Market More...

• Johnson & Johnson (JNJ) to Pay $2.2 Billion to End Risperdal Sales Probe More...

• FDA Approves Roche (RHHBY)'s New Breast Cancer Drug More...

• FDA Delays Its Decision on Gilead Sciences, Inc. (GILD)'s Anti-HIV Pill More...

• Sanofi (France) (SAN.PA) Seeks Approval for Diabetes Drug in Japan More...

• AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-923 For The Treatment Of Agitation In Patients With Alzheimer's Disease More...

• Sanofi (France) (SAN.PA)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc. (MRK)'s Januvia More...

• Novo Nordisk A/S (NVO) Says Victoza Superior to Amylin Pharmaceuticals, Inc. (AMLN) Rival More...

• Johnson & Johnson (JNJ) Diabetes Drug Tops Older Therapies in Studies More...

• GlaxoSmithKline (GSK) Reports Data From Phase III Study of Once-weekly Albiglutide in Type 2 Diabetes More...

• ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Dosing of First Patient in Phase 3 Study of Palifosfamide for the Treatment of Small Cell Lung Cancer More...

• Too Little Sleep Tied to Stroke Risk, University of Alabama at Birmingham Study More...

• Scientists Spot More Migraine Genes, Am van den Maagdenberg of Leiden University Medical Centre Study More...

• Harvard School of Public Health Study Digs Into Secrets of Keeping HIV in Check More...

• Early Menopause Predicts a Milder Form of Rheumatoid Arthritis, Skane University Hospital Study More...

• Physician Therapeutics, Inc. Release: Clinical Trial Shows Theramine® is Safe and Effective for Chronic Back Pain More...

• Mountain View Pharmaceuticals, Inc. Receives European Patent on Potential Long-Acting Drug for Multiple Sclerosis More...

• PIK3CA Gene Patent for Predicting Response to Targeted Therapy Issued - Exclusively Licensed to Transgenomic, Inc. (TBIO) More...